Please ensure Javascript is enabled for purposes of website accessibility
ホーム > 製品 > 抗体 > 中和抗体

Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12) (MS870207)

Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12)
Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12)
価格(USD): $
スペック:
  • 50ug
  • 100ug
数量:
お問い合わせ
  • 概要

  • イメージ

  • 参考文献

  • データシート

概要
カタログ番号MS870207
説明
Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12) [29F.1A12] (MS870207) is a rat monoclonal antibody detecting PDCD1 in FCM, IF, IHC, Neutralization, WB. Suitable for Mouse.
Highlights
  • Multi-Application — Validated across multiple applications.
  • Flow Cytometry — Validated for flow cytometry applications.
種反応性Mouse
アプリケーションFCM, IF, IHC, Neutralization, WB
宿主種Rat
アイソタイプIgG2a, kappa
クローンID29F.1A12
クローン性 Monoclonal
ターゲット Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279
エンドトキシンレベル Please contact with the lab for this information.
純度 >95% as determined by SDS-PAGE.
精製 Protein A/G purified from cell culture supernatant.
アクセッション番号 Q02242
形態 Liquid
保存バッファー 0.01M PBS, pH 7.4.

データシートのハードコピーまたはロット固有のCOAに記載された具体的なバッファー情報を参照してください。

安定性と保存 Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
背景

Programmed cell death protein 1 (CD279/PD-1) is a ~31 kDa protein. Inhibitory receptor on antigen activated T-cells that plays a critical role in induction and maintenance of immune tolerance to self. Delivers inhibitory signals upon binding to ligands, such as CD274/PDCD1L1 and CD273/PDCD1LG2. Following T-cell receptor (TCR) engagement, PDCD1 associates with TCR-CD3 in the immunological synapse and directly inhibits T-cell activation. Suppresses T-cell activation through the recruitment of PTPN11/SHP-2: following ligand-binding, PDCD1 is phosphorylated within the ITSM motif, leading to the recruitment of the protein tyrosine phosphatase PTPN11/SHP-2 that mediates dephosphorylation of key TCR proximal signaling molecules, such as ZAP70, PRKCQ/PKCtheta and CD247/CD3zeta. The PDCD1-mediated inhibitory pathway is exploited by tumors to attenuate anti-tumor immunity and facilitate tumor survival. CD279 is the therapeutic target of pembrolizumab (Keytruda) and nivolumab (Opdivo).

1. Nishimura, H. et al. (1999) Immunity 11, 141-51. PMID: 10485649
2. Nishimura, H. et al. (2001) Science (New York, N.Y.) 291, 319-22. PMID: 11209085
3. Okazaki, T. et al. (2001) Proceedings of the National Academy of Sciences of the United States of America 98, 13866-71. PMID: 11698646
4. Okazaki, T. et al. (2011) The Journal of experimental medicine 208, 395-407. PMID: 21300912
5. Freeman, GJ. et al. (2000) The Journal of experimental medicine 192, 1027-34. PMID: 11015443
6. Latchman, Y. et al. (2001) Nature immunology 2, 261-8. PMID: 11224527
7. Lin, DY. et al. (2008) Proceedings of the National Academy of Sciences of the United States of America 105, 3011-6. PMID: 18287011
8. Lázár-Molnár, E. et al. (2008) Proceedings of the National Academy of Sciences of the United States of America 105, 10483-8. PMID: 18641123
9. Yokosuka, T. et al. (2012) The Journal of experimental medicine 209, 1201-17. PMID: 22641383
注意事項 For research use only.
イメージ
  • Anti-Mouse CD279/PDCD1/PD1 Antibody (29F.1A12)

    Bioactivity

    Detects recombinant mouse PD1 (Cat No.: MS870011) in indirect ELISA.

参考文献
Formula
Mass (g) = Concentration (mol/L) × Volume (L) × MW (g/mol)
Enter any 2 of Mass, Concentration, Volume + Molecular Weight to solve for the unknown.
Mass
=
Concentration
×
Volume
Molecular Weight *
g/mol
Formula
C₁ × V₁ = C₂ × V₂
Enter any 3 of the 4 values to solve for the unknown.
Stock Solution
C₁ (Stock Conc.)
×
V₁ (Stock Vol.)
=
Working Solution
C₂ (Working Conc.)
×
V₂ (Working Vol.)
レコメンデーション

お問い合わせ カスタムクォート、大量リクエストおよびその他の問題については

メール: support@abinScience.com

ディストリビューターリスト